Circulating giant macrophages as a potential biomarker of solid tumorsDaniel L. Adams, Massimo Cristofanilli, Stuart S. Martin et al.|Proceedings of the National Academy of Sciences|2014Cited by 281
Cancer-associated macrophage-like cells as prognostic indicators of overall survival in a variety of solid malignancies.Daniel L. Adams, R. Katherine Alpaugh, Diane K. Adams et al.|Journal of Clinical Oncology|2017Cited by 15
Correlation of cancer-associated macrophage-like cells with systemic therapy and pathological stage in numerous malignancies.Daniel L. Adams, Martin J. Edelman, Raymond C. Bergan et al.|Journal of Clinical Oncology|2015Cited by 4
754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)David R. Spigel, Heidi H. Gillenwater, Lubna N. Chaudhary et al.|Regular and Young Investigator Award Abstracts|2023Cited by 4